PL1891004T3 - Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych - Google Patents

Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych

Info

Publication number
PL1891004T3
PL1891004T3 PL06753678T PL06753678T PL1891004T3 PL 1891004 T3 PL1891004 T3 PL 1891004T3 PL 06753678 T PL06753678 T PL 06753678T PL 06753678 T PL06753678 T PL 06753678T PL 1891004 T3 PL1891004 T3 PL 1891004T3
Authority
PL
Poland
Prior art keywords
pentafluorosulphanyl
substituted compound
producing medicaments
medicaments
compounds
Prior art date
Application number
PL06753678T
Other languages
English (en)
Inventor
Robert Frank
Bernd Sundermann
Hans Schick
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of PL1891004T3 publication Critical patent/PL1891004T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL06753678T 2005-05-20 2006-05-17 Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych PL1891004T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005023943A DE102005023943A1 (de) 2005-05-20 2005-05-20 Pentafluorsulfanyl-substituierte Verbindung und deren Verwendung zur Herstellung von Arzneimitteln
PCT/EP2006/004658 WO2006122773A1 (de) 2005-05-20 2006-05-17 Pentafluorsulfanyl-substituierte verbindung und deren verwendung zur herstellung von arzneimitteln
EP06753678A EP1891004B1 (de) 2005-05-20 2006-05-17 Pentafluorsulfanyl-substituierte verbindung und deren verwendung zur herstellung von arzneimitteln

Publications (1)

Publication Number Publication Date
PL1891004T3 true PL1891004T3 (pl) 2010-05-31

Family

ID=36733301

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06753678T PL1891004T3 (pl) 2005-05-20 2006-05-17 Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych

Country Status (7)

Country Link
US (1) US7994167B2 (pl)
EP (1) EP1891004B1 (pl)
AT (1) ATE450501T1 (pl)
DE (2) DE102005023943A1 (pl)
ES (1) ES2337723T3 (pl)
PL (1) PL1891004T3 (pl)
WO (1) WO2006122773A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8536168B2 (en) 2007-03-15 2013-09-17 Novartis Ag Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway
DE102007017884A1 (de) 2007-04-13 2008-10-16 Grünethal GmbH Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln
AU2008238250B2 (en) * 2007-04-16 2013-01-24 Grunenthal Gmbh Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
DE102007018149A1 (de) 2007-04-16 2008-10-23 Grünenthal GmbH Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
EP2440053A4 (en) 2009-06-09 2012-10-31 California Capital Equity Llc BENZYL SUBSTITUTED TRIAZINE DERIVATIVES AND THERAPEUTIC APPLICATIONS THEREOF
CA2765030C (en) 2009-06-09 2015-10-27 California Capital Equity, Llc Triazine derivatives and their therapeutical applications
WO2010144586A1 (en) 2009-06-09 2010-12-16 Abraxis Bioscience, Llc Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
WO2011044185A2 (en) 2009-10-08 2011-04-14 Schering Corporation Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
WO2011044187A1 (en) 2009-10-08 2011-04-14 Schering Corporation Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
WO2011044184A1 (en) * 2009-10-08 2011-04-14 Schering Corporation Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
UA108363C2 (uk) 2009-10-08 2015-04-27 Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
EP2694521B1 (en) 2011-04-07 2015-11-25 Merck Sharp & Dohme Corp. Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
WO2012138734A1 (en) 2011-04-07 2012-10-11 Merck Sharp & Dohme Corp. C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
RU2014111055A (ru) 2011-08-22 2015-09-27 Мерк Шарп И Доум Корп. 2-спирозамещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов bace, композиции и их применение
CN104788366A (zh) * 2014-01-21 2015-07-22 王若文 Raf激酶抑制剂五氟化硫基芳基脲及其制备方法和应用
MY195016A (en) 2014-08-04 2023-01-03 Nuevolution As Optionally Fused Heterocyclyl-Substituted Derivatives of Pyrimidine Useful for The Treatment of Inflammatory, Metabolic, Oncologic and Autoimmune Diseases
CN108863949B (zh) * 2018-07-09 2021-01-15 湖南博隽生物医药有限公司 一种用于治疗慢性炎性痛的辣椒素受体拮抗剂及合成方法
CN111454186B (zh) * 2019-01-18 2022-11-08 山东省联合农药工业有限公司 一种含五氟硫基的芳基甲酰苯胺类化合物及其制备方法与用途
AU2020405446A1 (en) 2019-12-20 2022-05-26 Nuevolution A/S Compounds active towards nuclear receptors
BR112022012205A2 (pt) 2019-12-20 2022-09-13 Nuevolution As Compostos ativos para receptores nucleares
CA3174252A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors
JP7713954B2 (ja) 2020-03-31 2025-07-28 ヌエヴォリューション・アクティーゼルスカブ 核内受容体に対して活性な化合物
KR102334947B1 (ko) * 2020-04-22 2021-12-06 주식회사 제이맥켐 Trpv1 길항제로서 벤즈이미다졸론계 시남아마이드 유도체 및 이를 유효성분으로 함유하는 통증의 치료 또는 예방용 약학적 조성물
CN118146112B (zh) * 2023-12-21 2025-11-18 南京理工大学 具有光学活性的辣椒素分子及其合成方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073861A (en) * 1959-08-13 1963-01-15 Du Pont Ureido-substituted arylsulfur pentafluorides
GB9515599D0 (en) * 1995-07-29 1995-09-27 British Nuclear Fuels Plc The preparation of fluorinated organic compounds
IL153884A0 (en) 2000-07-20 2003-07-31 Neurogen Corp Capsaicin receptor ligands
NZ523882A (en) 2000-08-21 2004-11-26 Pacific Corp Novel thiourea derivatives and the pharmaceutical compositions containing the same
EP1311478B1 (en) 2000-08-21 2006-06-07 Pacific Corporation Novel (thio)urea compounds and the pharmaceutical compositions containing the same
DE60325834D1 (de) 2002-02-20 2009-03-05 Abbott Lab Kondensierte azabicyclischeverbindungen als inhibitoren des vanilloid-rezeptors 1 (vr1)
GB0206876D0 (en) 2002-03-22 2002-05-01 Merck Sharp & Dohme Therapeutic agents
EP1506167B1 (en) 2002-05-08 2007-08-29 Bayer HealthCare AG Hydroxy tetrahydro-naphthalenylurea derivatives
EP1538138A4 (en) * 2002-08-26 2007-07-25 Nissan Chemical Ind Ltd SUBSTITUTED BENZANILIDE COMPOUND AND PROTECTIVE AGENTS
AU2003270199A1 (en) 2002-09-13 2004-04-30 Glaxo Group Limited Urea compounds active as vanilloid receptor antagonists for the treatment of pain
US6933311B2 (en) 2003-02-11 2005-08-23 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
GB0303910D0 (en) 2003-02-20 2003-03-26 Merck Sharp & Dohme Therapeutic agents
WO2004089877A1 (en) 2003-04-14 2004-10-21 Astrazeneca Ab New hydroxynaphthyl amides
ATE556067T1 (de) 2003-05-20 2012-05-15 Ajinomoto Kk Modulatoren des vanilloid rezeptors
US20050004133A1 (en) 2003-06-05 2005-01-06 Makings Lewis R. Modulators of VR1 receptor
KR100707123B1 (ko) 2003-07-02 2007-04-16 그뤼넨탈 게엠베하 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
EP1651636A1 (en) 2003-07-10 2006-05-03 Neurogen Corporation Substituted heterocyclic diarylamine analogues
EP1651619A1 (en) 2003-07-15 2006-05-03 Neurogen Corporation Substituted pyrimidin-4-ylamin analogues as vanilloid receptor ligands
WO2005009980A1 (en) 2003-07-22 2005-02-03 Neurogen Corporation Substituted pyridin-2-ylamine analogues
EP1648878B9 (en) 2003-07-24 2011-03-16 Euro-Celtique S.A. Piperidine compounds and pharmaceutical compositions containing them
GB0325287D0 (en) * 2003-10-29 2003-12-03 Merck Sharp & Dohme Therapeutic agents
WO2008102232A1 (en) * 2007-02-21 2008-08-28 Pfizer Limited Benzofuran antiparasitic agents

Also Published As

Publication number Publication date
ATE450501T1 (de) 2009-12-15
US20090137594A1 (en) 2009-05-28
WO2006122773A1 (de) 2006-11-23
ES2337723T3 (es) 2010-04-28
DE502006005523D1 (de) 2010-01-14
EP1891004B1 (de) 2009-12-02
US7994167B2 (en) 2011-08-09
DE102005023943A1 (de) 2006-11-23
EP1891004A1 (de) 2008-02-27

Similar Documents

Publication Publication Date Title
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
PL1888541T3 (pl) Związki benzo[d]izoksazol-3-iloaminy i ich zastosowanie jako ligandów receptora waniloidowego
IL190654A (en) Methods of Methyl-Sulfonamido-Propanamido, Processes for Preparation and Medicines Containing Them
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
DE502006005523D1 (de) Pentafluorsulfanyl-substituierte verbindung und deren verwendung zur herstellung von arzneimitteln
EA200702329A1 (ru) Замещенные пирролпиридины, содержащие их композиции, способ получения и применение
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
DE602004024213D1 (en) Aminopropanolderivate
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
MX2009004983A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
MY146671A (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
TW200740814A (en) Compounds
TW200700064A (en) Novel compounds
PL1758852T3 (pl) Podstawione związki cyklopentenu
MX2008011576A (es) Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
TW200745039A (en) Isotopically substituted pantoprazole
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
WO2006122769A3 (de) Substituierte spiro-verbindungen und deren verwendung zur herstellung von arzneimitteln gegen schmerz
TW200728310A (en) Process for the preparation of ferri-succinylcasein